Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma

Fig. 3

Validation of melanocyte and fibroblast cell systems for experimental depletion of DNMT1. a The DNMT1 mRNA expression levels were measured by quantitative RT-PCR in HNEM-hTERT- and BJ-hTERT-derived pTctrl and pTshDNMT1 clones. The clones were exposed (+ doxy) or not (− doxy) to doxycycline (1 μg/mL—7 days). Expression values represent the mean (± sem) of at least three independent experiments. ****p < 0.0001. b Protein levels of DNMT1 and pKu80 (a loading control) were evaluated by Western-blot in the different clones, either with or without exposure to doxycycline. c The number of population doublings of HNEM-hTERT- and BJ-hTERT-derived clones, with or without 7 and 14 days doxycycline exposure, were determined by cell counting. Results derive from two independent experiments. d FACS analysis was performed on HNEM-hTERT- and BJ-hTERT-derived pT-shDNMT1 clones exposed or not to doxycycline (7 days). Propidium iodide staining (X axis) was measured and the percentage of cells in each cell cycle phase was determined

Back to article page